Funding Briefs

This Time They Really Mean It The first time NSF ran its competition for science and technology centers, a fleet of Federal Express trucks pulled up to the agency’s loading dock on the Jan. 15, 1988, deadline and disgorged telephone-book-sized proposals. The length and complexity of many of the 323 proposals.threatened to oveiwhelm the agency’s merit review system. There’s got to be a better way, thought program director William Harris. So this year, as part of its second r

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

The first time NSF ran its competition for science and technology centers, a fleet of Federal Express trucks pulled up to the agency’s loading dock on the Jan. 15, 1988, deadline and disgorged telephone-book-sized proposals. The length and complexity of many of the 323 proposals.threatened to oveiwhelm the agency’s merit review system. There’s got to be a better way, thought program director William Harris.

So this year, as part of its second round of proposals, NSF revised the submission requirements. Page limits were set for each section of the application, and no page was to exceed about 400 words. In bold type, NSF warned institutions that those who failed to comply would be disqualified. But old habits die hard. A few days after this year’s August 4 deadline, Harris did a spot check of about half the 147 proposals and found that most had violated the specified format. Some eager ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies